Response to: 'High risk of systemic lupus erythematosus development in patients with ITP: antiphospholipid syndrome is also a concern?' by Inanc et al
- PMID: 32988836
- DOI: 10.1136/annrheumdis-2020-218402
Response to: 'High risk of systemic lupus erythematosus development in patients with ITP: antiphospholipid syndrome is also a concern?' by Inanc et al
Keywords: antiphospholipid syndrome; immune system diseases; lupus erythematosus; systemic.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a population-based cohort study.Ann Rheum Dis. 2020 Jun;79(6):793-799. doi: 10.1136/annrheumdis-2020-217013. Epub 2020 Apr 2. Ann Rheum Dis. 2020. PMID: 32241798
-
High risk of systemic lupus erythematosus development in patients with ITP: antiphospholipid syndrome is also a concern.Ann Rheum Dis. 2022 Jul;81(7):e110. doi: 10.1136/annrheumdis-2020-218345. Epub 2020 Aug 21. Ann Rheum Dis. 2022. PMID: 32826277 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
